Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

International Journal of Antimicrobial Agents

Volumn 25, Issue 1, 2005, Pages 11-25

  Li, Jian ^a   Nation, Roger L ^a   Milne, Robert W ^b   Turnidge, John D ^c   Coulthard, Kingsley ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Activity; Colistin; Pharmacodynamics; Pharmacokinetics; Resistance

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; COLISTIMETHATE; COLISTIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CYSTIC FIBROSIS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; EXPERIMENTAL RAT; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 11144285626     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.10.001     Document Type: Short Survey

References (170)

1. J. Travis Reviving the antibiotic miracle? Science 264 1994 360 362
2. S.B. Levy Factors impacting on the problem of antibiotic resistance J Antimicrob Chemother 49 2002 25 30
3. NNIS, National Nosocomial Infections Surveillance (NNIS) system report, data summary from October 1986-April 1998. Am J Infect Control 1998;26:522-33.
4. M.L. Hutchison, and J.R. Govan Pathogenicity of microbes associated with cystic fibrosis Microbes Infect 1 1999 1005 1014
5. B. Tummler, and C. Kiewitz Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections Mol Med Today 5 1999 351 358
6. J.B. Lyczak, C.L. Cannon, and G.B. Pier Lung infections associated with cystic fibrosis Clin Microbiol Rev 15 2002 194 222
7. N. Troillet, M.H. Samore, and Y. Carmeli Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns Clin Infect Dis 25 1997 1094 1098
8. A. Oliver, R. Canton, and P. Campo High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection Science 288 2000 1251 1254
9. D. Banerjee, and D. Stableforth The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs 60 2000 1053 1064
10. G. Doring, S.P. Conway, and H.G. Heijerman Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus Eur Respir J 16 2000 749 767
11. G.W. Waterer, and R.G. Wunderink Increasing threat of Gram-negative bacteria Crit Care Med 29 2001 N75 N81
12. D.M. Livermore Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34 2002 634 640
13. P.R. Hsueh, L.J. Teng, and P.C. Yang Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit J Clin Microbiol 36 1998 1347 1351
14. J.W. Mouton, J.G. den Hollander, and A.M. Horrevorts Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis J Antimicrob Chemother 31 1993 919 926
15. V. Krcmery, and J. Trupl Nosocomial outbreak of meropenem resistant Pseudomonas aeruginosa infections in a cancer centre J Hosp Infect 26 1994 69 71
16. D. Armstrong, H. Neu, and L.R. Peterson The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s Microb Drug Resist 1 1995 1 4
17. P. Beringer The clinical use of colistin in patients with cystic fibrosis Curr Opin Pulm Med 7 2001 434 440
18. E. Bergogne-Berezin, and K.J. Towner Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features Clin Microbiol Rev 9 1996 148 165
19. E. Bouza, and E. Cercenado Klebsiella and Enterobacter: antibiotic resistance and treatment implications Semin Respir Infect 17 2002 215 230
20. R.N. Jones Resistance patterns among nosocomial pathogens: trends over the past few years Chest 119 2001 397S 404S
21. J. Tankovic, P. Legrand, and G. De Gatines Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods J Clin Microbiol 32 1994 2677 2681
22. T. Jensen, S.S. Pedersen, and S. Garne Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection J Antimicrob Chemother 19 1987 831 838
23. J.M. Littlewood, C. Koch, and P.A. Lambert A ten year review of colomycin Respir Med 94 2000 632 640
24. M.E. Evans, D.J. Feola, and R.P. Rapp Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant Gram-negative bacteria Ann Pharmacother 33 1999 960 967
25. T.L. Pitt, M. Sparrow, and M. Warner Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents Thorax 58 2003 794 796
26. A. Stein, and D. Raoult Colistin: an antimicrobial for the 21st century? Clin Infect Dis 35 2002 901 902
27. S.P. Conway, K.G. Brownlee, and M. Denton Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis Am J Respir Med 2 2003 321 332
28. P. Linden, S. Kusne, and K. Coley Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa Clin Infect Dis 37 2003 E154 E160
29. A. Karabinis, E. Paramythiotou, and D. Mylona-Petropoulo Colistin for Klebsiella pneumoniae-associated sepsis Clin Infect Dis 38 2004 e7 e9
30. J. Li, R.W. Milne, and R.L. Nation A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 761 2001 167 175
31. J. Li, R.W. Milne, and R.L. Nation Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography Antimicrob Agents Chemother 46 2002 3304 3307
32. G.C. Ainsworth, A.M. Brown, and G. Brownlee 'Aerosporin', an antibiotic produced by Bacillus aerosporus Greer Nature 160 1947 263
33. R.G. Benedict, and A.F. Langlykke Antibiotic activity of Bacillus polymyxa J Bacteriol 54 1947 24 25
34. P.G. Stansly, R.G. Shepherd, and H.J. White Polymyxin: a new chemotherapeutic agent Johns Hopk Hosp Bull 81 1947 43 54
35. Y. Koyama, A. Kurosasa, and A. Tsuchiya A new antibiotic 'colistin' produced by spore-forming soil bacteria J Antibiot 3 1950 457 458
36. T. Suzuki, K. Hayashi, and K. Fujikawa The chemical structure of polymyxin E: the identities of polymyxin E1 with colistin A and polymyxin E2 with colistin B J Biochem (Tokyo) 57 1965 226 227
37. S. Ross, J. Puig, and E.A. Zaremba Colistin: some preliminary laboratory and clinical observations in specific gastroenteritis in infants and children Antibiot Ann 1959/1960 1960 89 100
38. K.J. Ryan, L.I. Schainuck, and R.O. Hickman Colistimethate toxicity. Report of a fatal case in a previously healthy child JAMA 207 1969 2099 2101
39. J. Koch-Weser, V.W. Sidel, and E.B. Federman Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy Ann Intern Med 72 1970 857 868
40. J.A. Bosso, C.A. Liptak, and D.K. Seilheimer Toxicity of colistin in cystic fibrosis patients DICP Ann Pharmacother 25 1991 1168 1170
41. M.J. Ledson, M.J. Gallagher, and C. Cowperthwaite Four years' experience of intravenous colomycin in an adult cystic fibrosis unit Eur Respir J 12 1998 592 594
42. E. Wolinsky, and J.D. Hines Neurotoxic and nephrotoxic effects of colistin in patients with renal disease N Engl J Med 266 1962 759 768
43. R.L. Perkins Apnea with intramuscular colistin therapy JAMA 190 1964 421 424
44. J.R. Lewis, and S.A. Lewis Colistin interactions with the mammalian urothelium Am J Physiol Cell Physiol 286 2004 C913 C922
45. D.J. Price, and D.I. Graham Effects of large doses of colistin sulphomethate sodium on renal function Br Med J 4 1970 525 527
46. M.D. Reed, R.C. Stern, and M.A. O'Riordan The pharmacokinetics of colistin in patients with cystic fibrosis J Clin Pharmacol 41 2001 645 654
47. F. O'Grady, and D. Greenwood Cyclic peptides F. O'Grady H.P. Lambert R.G. Finch D. Greenwood Antibiotic and chemotherapy: anti-infective agents and their use in therapy 1997 Churchill Livingstone Singapore 336 343
48. S.P. Conway, M.N. Pond, and A. Watson Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis Thorax 52 1997 987 993
49. C.R. Catchpole, J.M. Andrews, and N. Brenwald A reassessment of the in-vitro activity of colistin sulphomethate sodium J Antimicrob Chemother 39 1997 255 260
50. S.P. Conway, C. Etherington, and J. Munday Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis Ann. Pharmacother. 34 2000 1238 1242
51. H. Hanberger, D. Diekema, and A. Fluit Surveillance of antibiotic resistance in European ICUs J. Hosp. Infect. 48 2001 161 176
52. J. Garnacho-Montero, C. Ortiz-Leyba, and F.J. Jimenez-Jimenez Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP Clin Infect Dis 36 2003 1111 1118
53. N. Markou, H. Apostolakos, and C. Koumoudiou Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients Crit Care 7 2003 R78 R83
54. J.A. Orwa, A. Van Gerven, and E. Roets Development and validation of a liquid chromatography method for analysis of colistin sulphate Chromatographia 51 2000 433 436
55. J.A. Orwa, C. Govaerts, and R. Busson Isolation and structural characterization of colistin components J Antibiot 54 2001 595 599
56. C. Govaerts, E. Adams, and A. Van Schepdael Hyphenation of liquid chromatography to ion trap mass spectrometry to identify minor components in polypeptide antibiotics Anal Bioanal Chem 377 2003 909 921
57. I. Elverdam, P. Larsen, and E. Lund Isolation and characterization of three new polymyxins in polymyxins B and E by high-performance liquid chromatography J Chromatogr 218 1981 653 661
58. A.H. Thomas, J.M. Thomas, and I. Holloway Microbiological and chemical analysis of polymyxin B and polymyxin E (colistin) sulfates Analyst 105 1980 1068 1075
59. Y. Ikai, H. Oka, and J. Hayakawa Total structures of colistin minor components J Antibiot 51 1998 492 498
60. D. Decolin, P. Leroy, and A. Nicolas Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues J Chromatogr Sci 35 1997 557 564
61. T. Kline, D. Holub, and J. Therrien Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides J Pept Res 57 2001 175 187
62. T. Bergan, and J. Fuglesang Polymyxin antibiotics: chemical and pharmacokinetic properties Antibiot Chemother 31 1982 119 144
63. B.S. Schwartz, M.R. Warren, and F.A. Barkley Microbiological and pharmacological studies of colistin sulphate and sodium colistin methanesulfonate Antibiot Ann 1959-1960 1960 41 60
64. J. Li, R.W. Milne, and R.L. Nation Stability of colistin and colistin methanesulfonate in aqueous media and plasma studied by high-performance liquid chromatography Antimicrob Agents Chemother 47 2003 1364 1370
65. J.A. Orwa, C. Govaerts, and K. Gevers Study of the stability of polymyxins B1, E1 and E2 in aqueous solution using liquid chromatography and mass spectrometry J Pharmaceut Biomed Anal 29 2002 203 212
66. F.C. Ninger, and B.S. Schwartz Colistin sulfate and colistimethate sodium J Am Pharm Assoc NS2 1962 215 217
67. M. Barnett, S.R. Bushby, and S. Wilkinson Sodium sulphomethyl derivatives of polymyxins Br J Pharmacol 23 1964 552 574
68. E.G. Beveridge, and A.J. Martin Sodium sulphomethyl derivatives of polymyxins Br J Pharmacol Chemother 29 1967 125 135
69. F.H. McMillan, and I.C. Pattison Sodium colistimethate. Part I: Dissociations of aminomethanesulfonates in aqueous solution J Pharm Sci 58 1969 730 737
70. J. Li, K. Coulthard, and R. Milne Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis J Antimicrob Chemother 52 2003 987 992
71. D.R. Storm, K.S. Rosenthal, and P.E. Swanson Polymyxin and related peptide antibiotics Annu Rev Biochem 46 1977 723 763
72. R.A. Dixon, and I. Chopra Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide Antimicrob Agents Chemother 29 1986 781 788
73. C.C. Chen, and D.S. Feingold Locus of divalent cation inhibition of the bactericidal action of polymyxin B Antimicrob Agents Chemother 2 1972 331 335
74. M. Schindler, and M.J. Osborn Interaction of divalent cations and polymyxin B with lipopolysaccharide Biochemistry 18 1979 4425 4430
75. A.A. Peterson, R.E. Hancock, and E.J. McGroarty Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa J Bacteriol 164 1985 1256 1261
76. J. Lopes, and W.E. Inniss Electron microscopy of the effect of polymyxin on Escherichia coli lipopolysaccharide J Bacteriol 100 1969 1128 1129
77. M. Koike, K. Iida, and T. Matsuo Electron microscopic studies on mode of action of polymyxin J Bacteriol 97 1969 448 452
78. K. Lounatmaa, and N. Nanninga Effect of polymyxin on the outer membrane of Salmonella typhimurium: freeze-fracture studies J Bacteriol 128 1976 665 667
79. R.E. Hancock, and D.S. Chapple Peptide antibiotics Antimicrob Agents Chemother 43 1999 1317 1323
80. K.R. Gardiner, P.J. Erwin, and N.H. Anderson Lactulose as an antiendotoxin in experimental colitis Br J Surg 82 1995 469 472
81. P. Escartin, J.A. Rodriguez-Montes, and V. Cuervas-Mons Effect of colistin on reduction of biliary flow induced by endotoxin in E. coli Dig Dis Sci 27 1982 875 879
82. H.S. Warren, S.A. Kania, and G.R. Siber Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide Antimicrob Agents Chemother 28 1985 107 112
83. C. Mestres, M.A. Alsina, and M.A. Busquets Interaction of colistin with lipids in liposomes and monolayers Int J Pharm 160 1998 99 107
84. V. Lorian The mode of action of antibiotics on Gram-negative bacilli Arch Intern Med 128 1971 623 632
85. J. Li, J. Turnidge, and R. Milne In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis Antimicrob Agents Chemother 45 2001 781 785
86. M. Lesmana, D.S. Subekti, and P. Tjaniadi Spectrum of vibrio species associated with acute diarrhea in North Jakarta, Indonesia Diagn Microbiol Infect Dis 43 2002 91 97
87. S. Greenfield, and D.S. Feingold The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens J Infect Dis 121 1970 555 558
88. T. Fosse, C. Giraud-Morin, and I. Madinier Induced colistin resistance as an identifying marker for Aeromonas phenospecies groups Lett Appl Microbiol 36 2003 25 29
89. N.A. Kuck In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima) Antimicrob Agents Chemother 9 1976 493 497
90. T. Schulin In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany J Antimicrob Chemother 49 2002 403 406
91. A.C. Nicodemo, M.R. Araujo, and A.S. Ruiz In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods J Antimicrob Chemother 53 2004 604 608
92. T.P. Felegie, V.L. Yu, and L.W. Rumans Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination Antimicrob Agents Chemother 16 1979 833 837
93. A.C. Gales, A.O. Reis, and R.N. Jones Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines J Clin Microbiol 39 2001 183 190
94. K. Laffineur, M. Janssens, and J. Charlier Biochemical and susceptibility tests useful for identification of nonfermenting Gram-negative rods J Clin Microbiol 40 2002 1085 1087
95. D.A. Dance, V. Wuthiekanun, and P. Naigowit Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE J Clin Pathol 42 1989 645 648
96. T.C. Eickhoff, and M. Finland Polymyxin B and colistin: in vitro activity against Pseudomonas aeruginosa Am J Med Sci 249 1965 172 174
97. N. Kosakai, and T. Oguri Distribution and changes of antibiotic susceptibility of genus Haemophilus Jpn J Antibiot 29 1976 159 166
98. C. Thornsberry, C.N. Baker, and L.A. Kirven In vitro activity of antimicrobial agents on Legionnaires disease bacterium Antimicrob Agents Chemother 13 1978 78 80
99. G.V. Doern, and S.A. Morse Branhamella (Neisseria) catarrhalis: criteria for laboratory identification J Clin Microbiol 11 1980 193 195
100. Y. Glupczynski, M. Delmee, and C. Bruck Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents Eur J Epidemiol 4 1988 154 157
101. J.A. Garcia-Rodriguez, M.I. Garcia-Garcia, and E. Garcia-Sanchez In vitro activity of 16 antimicrobial agents against Helicobacter (Campylobacter) pylori Enferm Infecc Microbiol Clin 7 1989 544 546
102. F. Aydin, H.I. Atabay, and M. Akan The isolation and characterization of Campylobacter jejuni subsp. jejuni from domestic geese (Anser anser) J Appl Microbiol 90 2001 637 642
103. J.A. Kiehlbauch, C.N. Baker, and I.K. Wachsmuth In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents Antimicrob Agents Chemother 36 1992 717 722
104. M. Maurin, S. Gasquet, and C. Ducco MICs of 28 antibiotic compounds for 14 Bartonella (formerly Rochalimaea) isolates Antimicrob Agents Chemother 39 1995 2387 2391
105. N.M. Nord, and P.D. Hoeprich Polymyxin B and colistin. A critical comparison N Engl J Med 270 1964 1030 1035
106. N.J. Goodwin Colistin and sodium colistimethate Med Clin North Am 54 1970 1267 1276
107. Committee MotSA. Comite de l'Antibiogramme de la Societe Francaise de Microbiologie report 2003. Int J Antimicrob Agents 2003;21:364-91.
108. J.M. Andrews BSAC standardized disc susceptibility testing method J Antimicrob Chemother 48 Suppl 1 2001 43 57
109. A. Barry Establishment of zone-size interpretative criteria. The antimicrobic susceptibility test: principles and practices 1976 Lea & Febiger New York, NY p. 196
110. D.N. Fish, S.C. Piscitelli, and L.H. Danziger Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies Pharmacotherapy 15 1995 279 291
111. M. Denton, K. Kerr, and L. Mooney Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center Pediatr Pulmonol 34 2002 257 261
112. M. Tamm, C. Eich, and R. Frei Inhaled colistin in cystic fibrosis Schweizerische Medizinische Wochenschrift 130 2000 1366 1372
113. T.I. Nicas, and R.E. Hancock Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin J Bacteriol 143 1980 872 878
114. M.L. Young, M. Bains, and A. Bell Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques Antimicrob Agents Chemother 36 1992 2566 2568
115. 2+ environments J Bacteriol 179 1997 7040 7045
116. P.H. Makela, M. Sarvas, and S. Calcagno Isolation and genetic characterization of polymyxin-resistant mutants of Salmonella FEMS Microbiol Lett 3 1978 323 326
117. M.R. Brown, E.M. Fenton, and W.M. Watkins Tetracycline-sensitive polymyxin-resistant Pseudomonas aeruginosa Lancet 2 1972 86
118. R.S. Conrad, and C. Galanos Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance Antimicrob Agents Chemother 33 1989 1724 1728
119. M. Vaara, T. Vaara, and M. Jensen Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium FEBS Lett 129 1981 145 149
120. M. Vaara, T. Vaara, and M. Sarvas Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium J Bacteriol 139 1979 664 667
121. M.R. Brown, and W.M. Watkins Low magnesium and phospholipid content of cell walls of Pseudomonas aeruginosa resistant to polymyxin Nature 227 1970 1360 1361
122. G.H. Shand, H. Anwar, and M.R. Brown Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion J Antimicrob Chemother 22 1988 811 821
123. X.Z. Li, L. Zhang, and K. Poole Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa J Antimicrob Chemother 45 2000 433 436
124. M. Germ, E. Yoshihara, and H. Yoneyama Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa Biochem Biophys Res Commun 261 1999 452 455
125. K. Poole Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms J Mol Microbiol Biotechnol 3 2001 255 264
126. G. Carroll, and W.F. Malette The use of colymycin in chronic urinary infections due to Pseudomonas aeruginosa J Urol 85 1961 86 88
127. E.M. Yow, E. Tan, and L. Shane Colistin (Coly-mycin) in resistant bacterial infections. A clinical appraisal Arch Intern Med 108 1961 664 670
128. A.S. Levin, A.A. Barone, and J. Penco Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clin Infect Dis 28 1999 1008 1011
129. N.H. Valerius, C. Koch, and N. Hoiby Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment Lancet 338 1991 725 726
130. J.M. Littlewood, M.G. Miller, and A.T. Ghoneim Nebulized colomycin for early pseudomonas colonization in cystic fibrosis Lancet 1 1985 865
131. B. Frederiksen, C. Koch, and N. Hoiby Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis Pediatr Pulmonol 23 1997 330 335
132. C. Vazquez, M. Municio, and M. Corera Early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis Acta Paediatr 82 1993 308 309
133. E.M. Westerman, P.P.H. Le Brun, and D.J. Touw Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study J Cystic Fibrosis 3 2004 23 28
134. P.P.H. Le Brun, A.H. de Boer, and G.P.M. Mannes Dry powder inhalation of antibiotics in cystic fibrosis therapy. Part 2: Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients Eur J Pharm Biopharm 54 2002 25 32
135. P.P. Le Brun, R.W. Brimicombe, and G.P. Mannes Advantages of colistin dry powder inhalation. Proof of principle Pediatr Pulmonol S20 2000 285
136. A.H. de Boer, P.P.H. Le Brun, and H.G. van der Woude Dry powder inhalation of antibiotics in cystic fibrosis therapy. Part 1: Development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle Eur J Pharm Biopharm 54 2002 17 24
137. P. Fernandez-Viladrich, X. Corbella, and L. Corral Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium Clin Infect Dis 28 1999 916 917
138. P. Leroy, D. Decolin, and S. Nicolas Residue determination of two co-administered antibacterial agents - cephalexin and colistin - in calf tissues using high-performance liquid chromatography and microbiological methods J Pharm Biomed Anal 7 1989 1837 1846
139. A.H. Thomas, and I. Holloway Thin-layer chromatographic method for the identification of the polymyxins J Chromatogr 161 1978 417 420
140. T. Kitagawa, W. Ohtani, and Y. Maeno Sensitive enzyme immunoassay of colistin and its application to detect residual colistin in rainbow trout tissue J Assoc Off Anal Chem 68 1985 661 664
141. H.K. Kristensen, and S.H. Hansen Separation of polymyxins by micellar electrokinetic capillary chromatography J Chromatogr 628 1993 309 315
142. T.J. Wall High-performace liquid chromatography of polymyxin B and colistin sulfate J Chromatogr 208 1981 118 123
143. Y. Kimura, H. Kitamura, and T. Araki Analytical and preparative methods for polymyxin antibiotics using high-performance liquid chromatography with a porous styrene-divinylbenzene copolyme packing J Chromatogr 206 1981 563 572
144. P.P.H. Le Brun, A.I. de Graaf, and A. Vinks High-performance liquid chromatographic method for the determination of colistin in serum Ther Drug Monit 22 2000 589 593
145. D.J. Gmur, C.R. Bredl, and S.J. Steele Determination of polymyxin E1 in rat plasma by high-performance liquid chromatography J Chromatogr B Analyt Technol Biomed Life Sci 789 2003 365 372
146. P. Furst, L. Pollack, and T.A. Graser Appraisal of four pre-column derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials J Chromatogr 499 1990 557 569
147. J. Li, R.W. Milne, and R.L. Nation Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration Antimicrob Agents Chemother 47 2003 1766 1770
148. J. Li, R.W. Milne, and R.L. Nation Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate J Antimicrob Chemother 53 2004 837 840
149. M.A. Sande, and D. Kaye Evaluation of methods for determining antibacterial activity of serum and urine after colistimethate injection Clin Pharmacol Ther 11 1970 873 882
150. A.A. Al-Khayyat, and A.L. Aronson Pharmacologic and toxicologic studies with the polymyxins. Part II: Comparative pharmacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs Chemotherapy 19 1973 82 97
151. G. Ziv, J.F. Nouws, and C.A. van Ginneken The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves J Vet Pharmacol Ther 5 1982 45 58
152. L. Renard, P. Sanders, and M. Laurentie Pharmacokinetics of colistin sulfate administered by intravenous and intramuscular routes in the calf Ann Rech Vet 22 1991 387 394
153. G. Brownlee, S. Bushby, and E. Short The chemotherapy and pharmacology of the polymyxins Br J Pharmacol 7 1952 170 188
154. W.A. Craig, and C.M. Kunin Dynamics of binding and release of the polymyxin antibiotics by tissues J Pharmacol Exp Ther 184 1973 757 765
155. C.M. Kunin Binding of antibiotics to tissue homogenates J Infect Dis 121 1970 55 64
156. C.M. Kunin, and A. Bugg Binding of polymyxin antibiotics to tissues. Major determinant of distribution and persistence in the body J Infect Dis 124 1971 394 400
157. G. Ziv, and F.G. Sulman Binding of antibiotics to bovine and ovine serum Antimicrob Agents Chemother 2 1972 206 213
158. B. Davies, and T. Morris Physiological parameters in laboratory animals and humans Pharm Res 10 1993 1093 1095
159. J.H. Birnie, and J. Grayson Observations on temperature distribution and liver blood flow in the rat J Physiol 116 1952 189 201
160. G. Chamberlain, and P. Needham The absorption of antibiotics from the bladder J Urol 116 1976 172 173
161. N.J. Goodwin, and E.A. Friedman The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels Ann Intern Med 68 1968 984 994
162. J. Froman, L. Gross, and S. Curatola Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals J Urol 103 1970 210 214
163. E.J. Pulaski, and M.H. Fusillo Gallbladder bile concentrations of the major antibiotics Surg Gynaecol Obstet 100 1955 571 574
164. C.M. Kunin A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels Ann Intern Med 67 1967 151 158
165. M. Abe, K. Shimizu, and M. Ouchi Studies on sodium colistin methane sulfonate (CL-M) on metabolism in the urine and bile of rabbits Chemotherapy 24 1976 1592 1596
166. R.G. Petersdorf, and J.J. Plorde Colistin - a reappraisal JAMA 183 1963 123 125
167. A. Montero, J. Ariza, and X. Corbella Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii Antimicrob Agents Chemother 46 2002 1946 1952
168. M.E. Jimenez-Mejias, C. Pichardo-Guerrero, and F.J. Marquez-Rivas Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis Eur J Clin Microbiol Infect Dis 21 2002 212 214
169. A.I. Duenas Diez, M.A. Bratos Perez, and J.M. Eiros Bouza Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin Int J Antimicrob Agents 23 2004 487 493
170. C.J. Henwood, T. Gatward, and M. Warner Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J Antimicrob Chemother 49 2002 479 487